Drug Shortage – Opana ER (oxymorphone hydrochloride) Extended-Release Tablets CII

February 8, 2012 – Endo Pharmaceuticals Inc. announces a shortage on the following products due to a manufacturing delay:

OPANA ER (oxymorphone hydrochloride) Extended-Release Tablets CII 10 mg NDC 63481-674-70

OPANA ER (oxymorphone hydrochloride) Extended-Release Tablets CII 20 mg NDC 63481-617-70

OPANA ER (oxymorphone hydrochloride) Extended-Release Tablets CII 30 mg NDC 63481-571-70

OPANA ER (oxymorphone hydrochloride) Extended-Release Tablets CII 40 mg NDC 63481-693-70

Anticipated availability:
10 mg tablets – anticipated availability mid-February 2012. (new formulation/new NDC).
20, 30 mg tablets – anticipated availability mid-February 2012.
40 mg tablets – anticipated availability late February 2012.

Endo Pharmaceuticals Inc.
Customer Service:
1-800-462-3636

Bookmark and Share